1. Editor's page

   EditorialNotes Pages: 121 - 121

2. Metabolites of tamoxifen in animals and man: Identification, pharmacology, and significance

   • V. Craig Jordan
   • C. Chem.

   Review Pages: 123 - 138

3. Luteal phase defect and breast cancer genesis

   • Pierre Mauvais-Jarvis
   • Régine Sitruk-Ware
   • Frédérique Kuttenn

   Review Pages: 139 - 150

4. The contralateral breast at reconstructive surgery after breast cancer operation — A histopathological study

   • Anita Ringberg
   • Björn Palmer
   • Folke Linell

   Report Pages: 151 - 161

5. Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer

   • Aman U. Buzdar
   • Terry L. Smith
   • Edmund A. Gehan

   Report Pages: 163 - 169

6. Estrogen receptor status as a prognostic indicator for stage I breast cancer patients

   • Joseph P. Crowe
   • Charles A. Hubay
   • Participating Investigators

   Report Pages: 171 - 176

7. Presurgical radiotherapy decreases the concentrations of estrogen and progesterone receptors in human breast cancer: A 200-patient study

   • N. Bressot
   • F. Veith
   • H. Rochefort

   Report Pages: 177 - 183

8. Variability of steroid receptors in multiple biopsies of breast cancer: Effect of systemic therapy

   • Yeu-Tsu N. (Margaret) Lee

   Report Pages: 185 - 193

9. Progesterone receptor as a more reliable prognostic parameter than estrogen receptor in patients with advanced breast cancer

   • H. Magdelénat
   • P. Pouillart
   • B. Asselain

   Correspondence Pages: 195 - 195

10. Book review

    • George W. Sledge Jr.

    BookReview Pages: 197 - 197